Stocks and Investing Stocks and Investing
Thu, November 30, 2023

Anupam Rama Maintained (VERA) at Buy with Decreased Target to $22 on, Nov 30th, 2023


Published on 2024-10-28 07:47:49 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Vera Therapeutics, Inc." (VERA) at Buy with Decreased Target from $25 to $22 on, Nov 30th, 2023.

Anupam has made no other calls on VERA in the last 4 months.



There are 4 other peers that have a rating on VERA. Out of the 4 peers that are also analyzing VERA, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $16 on, Friday, August 11th, 2023


These are the ratings of the 3 analyists that currently disagree with Anupam


  • Farzin Haque of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $26 on, Friday, November 10th, 2023
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $25 on, Tuesday, September 26th, 2023
  • Vamil Divan of "Guggenheim" Initiated at Strong Buy and Held Target at $27 on, Wednesday, August 16th, 2023
Contributing Sources